Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The site’s displayed revision/version has been updated from v3.5.2 to v3.5.3, indicating a minor backend/UI release rather than a change to the study record.
    Difference
    0.0%
    Check dated 2026-04-27T07:40:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T03:00:18.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Location entry updated from Padua, Italy 35128 to Padova, Italy 35128.
    Difference
    0.0%
    Check dated 2026-04-05T16:52:14.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations list, and the page revision changed from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T07:53:30.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Page revision from v3.4.2 to v3.4.3; no visible changes to study details, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2026-03-07T19:16:32.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T04:40:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.